Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity

Immunity

Volumn 4, Issue 3, 1996, Pages 275-281

  Kamanaka, Masahito ^b   Yu, Philipp ^b   Yasui, Teruhito ^b   Yoshida, Kenji ^b   Kawabe, Tsutomu ^b   Horii, Toshihiro ^b   Kishimoto, Tadamitsu ^a   Kikutani, Hitoshi ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; PARASITE ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; HELPER CELL; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029933509     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80435-5     Document Type: Article

References (53)

1. Alderson, M.R., Armitage, R.J., Tough, T.W., Strockbine, L., Fanslow, W.C., and Spriggs, M.K. (1993). CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178, 669-674.
2. Allen, R.C., Armitage, R.J., Conley, M.E., Rosenblatt, H., Jenkins, N.A., Copeland, N.G., Bedell, M.A., Edelhoff, S., Disteche, C.M., Simoneaux, D.K., Fanslow, W.C., Belmont, J., and Spriggs, M.K. (1993). CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259, 990-993.
3. Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L.S., Stenkamp, R., Neubauer, M., Roberts, R.L., Noelle, R.J., Ledbetter, J.A., Freekel, U., and Ochs, H.D. (1993). The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72, 291-300.
4. Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J.H., Lanier, L.L., and Somoza, C. (1993). B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366, 76-79.
5. Banchereau, J., Bazan, F., Blanchard, D., Brière, F., Galizzi, J.P., van Kooten, C., Liu, Y.J., Rousset, F., and Saeland, S. (1994). The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881-922.
6. Belosevic, M., Finbloom, D.S., van der Meide, P.M., Slayter, M.V., and Nancy, C.A. (1989). Administration of monoclonal anti-IFN γ in vivo abrogates resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143, 266-274.
7. Boom, W.H., Liebster, L., Abbas, A.K., and Titus, R.A. (1990). Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution. Infect. Immun. 58, 3863-3870.
8. Bouaboula, M., Legoux, P., Pessegue, B., Delpech, B., Dumont, X., Piechaczyk, M., Casellas, P., and Shire, D. (1992). Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J. Biol. Chem. 267, 21830-21838.
9. Castigli, E., Alt, F.W., Davidson, L., Bottaro, A., Mizoguchi, E., Bhan, A.K., and Geha, R.S. (1994). CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA 91, 12135-12139.
10. Caux, C., Vanbervliet, B., Massactier, C., Azuma, M., Okumura, K., Lanier, L., and Banchereau, J. (1994). B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. Exp. Med. 180, 1841-1847.
11. DiSanto, J.P., Bonnefoy, J.Y., Gauchat, J.F., Fischer, A., and de Saint Basile, G. (1993). CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361, 541-543.
12. Durie, F.H., Fava, R.A., Foy, T.M., Aruffo, A., Ledbetter, A., and Noelle, R.J. (1993). Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261, 1328-1330.
13. Durie, F.H., Aruffo, A., Ledbetter, J., Crassi, K.M., Green, W.R., Fast, L.D., and Noelle, R.J. (1994). Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J. Clin. Invest. 94, 1333-1338.
14. Freedman, A.S., Freeman, G.J., Rhynhart, K., and Nadler, L.M. (1991). Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: a potential mechanism for amplification of T cell activation. Cell. Immunol. 137, 429-437.
15. Freeman, G.J., Boussiotis, V.A., Anumanthan, A., Bernstein, G.M., Ke, X.-Y., Rennert, P.D., Gray, G.S., Gribben, J.G., and Nadler, L.M. (1995). B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2, 523-532.
16. Grewal, I.S., Xu, J., and Flavell, R.A. (1995). Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378, 617-620.
17. Hart, D.N.J., and McKenzie, J.L. (1988). Isolation and characterization of human tonsil dendritic cells. J. Exp. Med. 168, 157-170.
18. Hart, D.N., Starling, G.C., Calder, V.L., and Fernando, N.S. (1993). B7/BB-1 is a leucocyte differentiation antigen on human dendritic cells induced by activation. Immunology 79, 616-620.
19. Heinzel, F.P., Sadick, M.D., Holaday, B.J., Coffman, R.L., and Locksley, R.M. (1989). Reciprocal expression of Interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169, 59-72.
20. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 88, 7011-7015.
21. Heinzel, F.P., Schoenhaut, D.S., Rerko, R.M., Rosser, L.E., and Gately, M.K. (1993). Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177, 1505-1509.
22. Holaday, B.J., Sadick, M.D., Wang, Z.-E, Reiner, S.L., Heinzel, F.P., Parslow, T.G., and Locksley, R.M. (1991). Reconstitution of leishmania immunity in severe combined immunodeficient mice using Th 1- and Th 2-like cell lines. J. Immunol. 147, 1653-1658.
23. + T cells occur through IL-12 produced by Listeria-induced macrophages. Science 260, 547-549.
24. Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., and Kikutani, H. (1994). The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167-178.
25. Korthäuer, U., Graf, D., Mages, H.W., Brière, F., Padayachee, M., Malcolm, S., Ugazio, A.G., Nortarangelo, L.D., Levinsky, R.J., and Kroczek, R.A. (1993). Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361, 539-541.
26. Kuchroo, V.K., Das, M.P., Brown, J.A., Ranger, A.M., Zamvil, S.S., Sobel, R.A., Weiner, H.L., Nabavi, N., and Glimcher, L.H. (1995). B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80, 707-718.
27. Larsen, C.P., Ritchie, S.C., Hendrix, R., Linsley, P.S., Hathcock, K.S., Hodes, R.J., Lowry, R.P., and Pearson, T.C. (1994). Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152, 5208-5219.
28. Liew, F.Y., and O'Donnell, C.A., (1993). Immunology of leishmaniasis. Adv. Parasitol. 32, 161-259.
29. Liew, F.Y., Millot, S., Parkinson, C., Palmer, R.M.J., and Moncada, S. (1990). Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 12, 4794-4797.
30. Manetti, R., Parronchi, P., Giudizi, M.G., Piccini, M.-P., Maggi, E., Trinchieri, G., and Romagnani, S. (1993). Natural killer cell stimulatory factor (NKSF/IL-12) induces Th1-type specific immune responses and inhibits the development of IL-4 producing Th cells. J. Exp. Med. 177, 1199-1204.
31. Manetti, R., Gerosa, F., Giudizi, M.G., Biagiotti, R., Parronchi, P., Piccini, M., Sampognaro, S., Maggi, E., Romagnani, S., and Trinchieri, G. (1994). Interleukin-12 induces stable priming for interferon-γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFNγ production in established Th2 cell clones. J. Exp. Med. 179, 1273-1283
32. Müller, I., Pedrazzini, T., Farrel, J.P., and Louis, J. (1989). T cell responses and immunity to experimental infection with Leishmania major. Annu. Rev. Immunol. 7, 561-578.
33. Nortarangelo, L.D., Duse, M., and Ugazio, A.G. (1992). Immunodeficiency with hyper-IgM (HIM), Immunodef. Rev. 3, 101-121.
34. Reiner, S.L., and Locksley, R.M., (1995). The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13, 151-177.
35. Renshaw, B.R., Fanslow, W.C., Armitage, R.J., Campbell, K.A., Liggitt, D., Wright, B., Davison, B.L., and Maliszewski, C.R. (1994). Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180, 1889-1900.
36. Sadick, M.D., Heinzel, F.P., Holaday, B.J., Pu, R.T., Dawkins, R.S., and Locksley, R.M. (1990). Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. J. Exp. Med. 171, 115-127.
37. + T cells to enhance priming for IFNγ production and diminishes IL-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90, 10188-10192.
38. Shire, D. (1993). An invitation to an open exchange of reagents and information useful for the measurement of cytokine mRNA levels by PCR. Eur. Cytokine Netw. 4, 161-162.
39. Shriever, F., Freedman, A.S., Freeman, G., Messner, E., Lee, G., Daley, J., and Nadler, L.M. (1989). Isolated follicular dendritic cells display a unique antigenic phenotype. J. Exp. Med. 169, 2043-2048.
40. Shu, U., Kiniwa, M., Wu, C.Y., Maliszewski, C.R., Vezzio, N., Hakimi, J., Gately, M., and Delespesse, G. (1995). Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25, 1125-1128.
41. Sypek, J.P., Chung, C.L., Mayor, S.E.H., Subramanyam, J.M., Goldman, S.J., Sieburth, D.S., Wolf, S.F., and Shaub, R.G. (1993). Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177, 1797-1802.
42. Taswell, C. (1981). Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126, 1614-1619.
43. Tian, L., Noelle, R.J., and Lawrence, D.A. (1995). Activated T cells enhance nitric oxide production by splenic macrophages through gp39 and LFA-1. Eur. J. Immunol. 25, 306-309.
44. Titus, R.G., Machand, M., Boon, T., and Louis, J.A. (1985). A limiting dilution assay for quantitating Leishmania major in tissue of infected mice. Parasite Immunol. 7, 545-555.
45. Tobin, J.F., Reiner, S.L., Hatam, F., Zheng, S., Leptak, C.L., Wirth, D.F., and Locksley, R.M. (1993). Transfected Leishmania expressing biologically active IFNγ. J. Immunol. 150, 5059-5069.
46. van Essen, D., Kikutani, H., and Gray, D. (1995). CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378, 620-623
47. Varkila, K., Chatelain, R., Leal, L.M., and Coffman, R.L. (1993). Reconstitution of C. B-17 seid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection. Eur. J. Immunol. 23, 262-268.
48. + T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur. J. Immunol. 24, 3148-3154.
49. + effector cells default to the Th2 pathway in interferon-γ-deficient mice infected with Leishmania. J. Exp. Med. 179, 1367-1371.
50. Wei, X.-Q., Chales, I.G., Smith, A., Ure, J., Feng, G.-J., Huang, F.-P., Xu, D., Mullers, W., Moncada, S., and Liew, F.Y. (1995). Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375, 408-411.
51. World Health Organization. (1990). Control of the leishmaniasis. Technical Report Sr. 793, 144-150.
52. Wu, C.Y., Demeure, C., Kiniwa, M., Gately, M., and Delespesse, G. (1993). IL-12 induces the production of IFN-γ by neonatal human CD4 T cells. J. Immunol. 151, 1938-1949.
53. Xu, J., Foy, T.M., Laman, J.D., Elliott, E.A., Dunn, J.J., Waldschmidt, T. J., Elsemore, J., Noelle, R.J., and Flavell, R.A.(1994). Mice deficient for the CD40 ligand. Immunity 1, 423-431.